Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02948335 · ClinicalTrials.gov registry record

Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital

A clinical trial of Infection, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
22
Enrollment target
1
Study location

NCT02948335: Completed study of Infection, sponsored by St. Jude Children's Research Hospital.

NCT02948335 is a study of Infection that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 22 participants, below the 726-participant average among 41 other Infection trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02948335, a study of Infection, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

Microorganisms that colonize hospital environments play an important role in the transmission of hospital acquired infections (HAI) and multi-drug resistant organisms. Previous studies examining microorganisms in the hospital environment have been limited by reliance on targeted culture-based methods resulting in potentially missed or unrecognized organisms. Evidence now suggests that using microbiome analysis offers an innovative strategy that may improve our understanding of HAI and how best to prevent them. This pilot longitudinal observational study aims to characterize the taxonomic composition of microbial communities on environmental surfaces and people in these environments prior to and following the introduction of patients, caregiver, and hospital staff to newly constructed inpatient care areas at St. Jude Children's Research Hospital (SJCRH). This proposed study is uniquely characterized by evaluating the hospital environment of a pediatric immunocompromised oncology patient population that has not been studied in the past using advanced molecular techniques such as microbiome analysis. PRIMARY OBJECTIVE: * To describe the pattern of microbial communities of the hospital environment before, during and after patient occupancy of a newly constructed hospital space. SECONDARY OBJECTIVES: * To describe the similarity or difference of environment microbial communities to that of the humans occupying this environment in a newly occupied hospital space. * To describe the pattern in environment microbial communities after each step of disinfection (manual cleaning with chemical disinfectant and Ultraviolet light disinfection machine) after patient discharge from the inpatient hospital environment. * To evaluate the correlation between environmental Adenosine Triphosphate (ATP) measures and organism bioburden.

Primary Outcome

Microbial flora colonizing a newly built hospital environment will be compared prior to participant inpatient admission to after inpatient hospital discharge. Microbiome diversity is a measure of the richness of microbial species present in the environmental sample. It is reported as diversity index.

Conditions Studied

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2017-02-23
Est. Completion 2018-02-19

What the finished NCT02948335 record still lists

NCT02948335 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 726-participant average among 41 other Infection trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Infection appearing as the primary indexed condition, and to 0 interventions.

NCT02948335 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT02948335 about?

NCT02948335 is a clinical study titled "Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital". Microorganisms that colonize hospital environments play an important role in the transmission of hospital acquired infections (HAI) and multi-drug resistant organisms. Previous studies examining microorganisms in the hospital environment have been limited by reliance on targeted culture-based method...

What is the current status of trial NCT02948335?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2017-02-23. Estimated completion is 2018-02-19.

What conditions does trial NCT02948335 study?

This clinical trial studies the following conditions: Infection.

Who is sponsoring clinical trial NCT02948335?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02948335 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02948335's enrollment target sits among peer trials

22 37th of 41 higher than 5 of 41 other Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02948335, the US trial registry maintained by the National Library of Medicine. NCT02948335 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.